Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian CancerJan P. Neijt, Hans C. van Houwelingen, Svend Aage Engelholm et al.|Journal of Clinical Oncology|2000Cited by 443
A systematic review of dual targeting in HER2-positive breast cancerIben Kümler, Dorte Nielsen, Malgorzata Tuxen|Cancer Treatment Reviews|2013Cited by 168